What is Apical Instruments?
Apical Instruments operates as a critical infrastructure provider in the medical technology ecosystem, bridging the gap between conceptual design and commercial-scale production. The firm distinguishes itself through a rigorous adherence to ISO 13485 standards and comprehensive FDA compliance protocols, which are essential for navigating the complex regulatory landscape of modern healthcare innovation. By offering end-to-end development services, Apical Instruments serves as a vital conduit for organizations seeking to transition from proof-of-concept to market-ready medical devices, effectively mitigating the risks associated with product lifecycle management and quality assurance.
How much funding has Apical Instruments raised?
Apical Instruments has raised a total of $379K across 2 funding rounds:
Debt
$150K
Debt
$229K
Debt (2020): $150K with participation from PPP
Debt (2021): $229K led by PPP
Key Investors in Apical Instruments
PPP
Public-Private Partnership
What's next for Apical Instruments?
With the recent infusion of capital, Apical Instruments is poised to scale its manufacturing capabilities and deepen its technical expertise in semiconductor-integrated medical hardware. The strategic focus will likely shift toward optimizing production throughput and expanding its footprint in international markets where regulatory compliance remains a significant barrier to entry. As the company matures, this late-stage financing provides the necessary runway to enhance its design control processes and invest in advanced prototyping technologies, ensuring that it remains at the forefront of the medical device industry's evolution toward more complex, data-driven diagnostic and therapeutic tools.
See full Apical Instruments company page
